Outcomes of Treatment With Combination Topical 5-Fluorouracil 5.0%/Calcipotriene 0.005% Cream in Patients With Cutaneous In Situ Squamous Cell Carcinoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Combination topical 5-fluorouracil 5%/calcipotriene 0.005% cream for the treatment of cutaneous in situ squamous cell carcinoma: a pilot study
J Am Acad Dermatol 2024 Aug 24;[EPub Ahead of Print], RT Patel, KK Fagan, EY Quan, NM Johnson, AN Tegge, AC Holliday, DJ Grider, PS Rush, KA Prickett, JD Eikenberg, MA PhillipsFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.